These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1953 related items for PubMed ID: 8345046

  • 1. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [Abstract] [Full Text] [Related]

  • 2. The effects of levonorgestrel, desogestrel and gestodene on the pulsatile release of luteinizing hormone in oral contraceptive users.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    Gynecol Endocrinol; 1993 Sep; 7(3):191-200. PubMed ID: 8291457
    [Abstract] [Full Text] [Related]

  • 3. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD.
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [Abstract] [Full Text] [Related]

  • 4. Pulsatile luteinizing hormone secretion during the first and the fourth cycle on two different oral contraceptives containing gestodene.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    Acta Endocrinol (Copenh); 1993 Sep; 129(3):229-36. PubMed ID: 8212988
    [Abstract] [Full Text] [Related]

  • 5. Influence of oral contraceptives on integrated secretion of gonadotropins.
    Dericks-Tan JS, Gudacker V, Taubert HD.
    Contraception; 1992 Oct; 46(4):369-77. PubMed ID: 1486775
    [Abstract] [Full Text] [Related]

  • 6. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 7. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM, Fauser BC.
    Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
    [Abstract] [Full Text] [Related]

  • 8. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA, Brenner PF, Kletzky OA, Mishell DR.
    Am J Obstet Gynecol; 1978 Apr 01; 130(7):817-21. PubMed ID: 345817
    [Abstract] [Full Text] [Related]

  • 9. The mechanism of action of a new low-dosed combined oral contraceptive.
    Dericks-Tan JS, Schneider K, Taubert HD.
    Arch Gynecol; 1980 Apr 01; 229(2):107-14. PubMed ID: 6768343
    [Abstract] [Full Text] [Related]

  • 10. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL, Katz M.
    Contraception; 1979 Nov 01; 20(5):475-87. PubMed ID: 393456
    [Abstract] [Full Text] [Related]

  • 11. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Jul 01; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 13. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS.
    Contraception; 1998 Jan 01; 57(1):39-44. PubMed ID: 9554249
    [Abstract] [Full Text] [Related]

  • 14. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
    Hemrika DJ, Slaats EH, Schoemaker J.
    Am J Obstet Gynecol; 1994 Feb 01; 170(2):462-8. PubMed ID: 8116698
    [Abstract] [Full Text] [Related]

  • 15. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT.
    Contraception; 1986 Nov 01; 34(5):513-22. PubMed ID: 3102162
    [Abstract] [Full Text] [Related]

  • 16. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P.
    Contraception; 1983 Jun 01; 27(6):577-90. PubMed ID: 6225622
    [Abstract] [Full Text] [Related]

  • 17. Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use.
    Jernstrom H, Knutsson M, Olsson H.
    Contraception; 1995 Jul 01; 52(1):51-6. PubMed ID: 8521715
    [Abstract] [Full Text] [Related]

  • 18. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL, Wang CF, Yen SS.
    J Clin Endocrinol Metab; 1975 Nov 01; 41(5):820-6. PubMed ID: 1102551
    [Abstract] [Full Text] [Related]

  • 19. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug 01; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 20. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR, Kletzky OA, Brenner PF, Roy S, Nicoloff J.
    Am J Obstet Gynecol; 1977 May 01; 128(1):60-74. PubMed ID: 403765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 98.